The King Hussein Cancer Center

The King Hussein Cancer Center (KHCC) is the leading cancer center in the Middle East region providing adult and pediatric patients with state-of-the-art comprehensive cancer care for all types of cancer. It is accredited by the Joint Commission International (JCI) as a disease-specific cancer center, making it the first center in the developing world and only the sixth worldwide to earn such a distinction. KHCC is led by Dr. Asem Mansour, the Director General.

KHCC has 37,000 active patients on its books. It treats over 4,000 new cancer cases each year and provides cancer treatment to over 110,000 outpatients annually. KHCC has established programs that focus on all stages of comprehensive cancer care: from prevention and early detection through diagnosis and treatment to palliative care. KHCC treats all cancers, in both adult and pediatric patients, and performs approximately 100 bone marrow transplants each year, achieving cure rates comparable with international standards.

KHCC is proud of its long-term partnerships and cooperative agreements with top cancer hospitals and organizations around the world, such as the University of Texas MD Anderson Cancer Center, the National Cancer Institute of the NIH and St. Jude Children’s Research Hospital. These collaborations provide the opportunity for an exchange of experiences and expertise as well as extensive research and the ability to sustain the highest levels of comprehensive cancer care.